Down Syndrome clinical trials at UCSD
2 in progress, 2 open to new patients
-
Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
open to eligible people ages 25-45
The purpose of this study is to test in adults with Down Syndrome the safety, tolerability and immunogenicity of a vaccine, ACI-24.
La Jolla, California and other locations
-
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
San Diego, California and other locations